Intellia Therapeutics' stock has experienced a significant surge, with its price increasing by 35% over the past month. The recent price movement has raised questions about whether the company's current pricing is reasonable. The justification for Intellia Therapeutics' current valuation is being evaluated in light of its recent stock performance.